RxDoctor Payments Data

Daniel Calderon, MD

Vascular Surgery · Chapel Hill, NCNPI 1982999496

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,976 of the $9,660 with a category attached, or 82.6%. 19 manufacturers reported payments, led by Medtronic at 24.3% of the total. Reporting peaked in 2024 at $4,102 and has fallen 77.1% since, to $939 in 2025.

$9,660in general payments, 2019–2025

Across 168 payments — averaging $57.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • W. L. Gore & Associates, Inc.$2K
  • Silk Road Medical, Inc.$2K
  • Penumbra, Inc.$1K
  • Shockwave Medical, Inc$900
  • Terumo Medical Corporation$207
  • plus $903 from 13 others
$52,210in research payments, 2019–2025

Across 15 payments — averaging $3480.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Silk Road Medical, Inc.$48K
  • Boston Scientific$4K

What the payments were for

  • Travel & lodging$1,68417%
  • Food & beverage$7,97683%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,660 in reported general payments places this provider in the 75th percentile of 119 vascular surgery providers in North Carolina.

See all vascular surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$93,899
Medicare patients
270
Services billed
532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate50$337

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →